An observational study in Ankylosing Spondylitis, sponsored by Bozyaka Training and Research Hospital. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-05-13.
Sponsored by Bozyaka Training and Research Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 84 studies in Spondylitis, Ankylosing with a site in Turkey — 19 open to participants now, 21 under way, none of them phase 3. Spondylitis, Ankylosing · Turkey.
Among the 84 studies in Spondylitis, Ankylosing with a site in Turkey, this one is the 11th largest by planned enrollment of the 35 observational ones that give a count, is one of 10 that started in 2021, is one of 35 observational ones, reaches primary completion later than 14 of the 20 other live ones, and was the 40th registered.
535 studies on the registry are indexed under Spondylitis, Ankylosing; 100 are open to participants now.
Browse Spondylitis, Ankylosing studies →19 of the 84 studies in Spondylitis, Ankylosing with a site in Turkey are open now. Recruiting first, the newest first:
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 18–65
Ankara Etlik City Hospital · Sites in Turkey
Ages 18–65
Marmara University · Sites in Turkey
Ages 18–65
Merve Şahin · Sites in Turkey
Ages 18–65 · Healthy volunteers
Konya Beyhekim Training and Research Hospital · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 63 Spondylitis, Ankylosing studies recruiting now, 24 (38%) set no upper age limit and 33 (52%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
84 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 10 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 130 is below the median of 201 across 216 observational studies indexed under Spondylitis, Ankylosing.
Median enrollment 60 across the 49 interventional studies, 100 across the 35 observational. Of the 54 that completed or were terminated, 11 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 84 have an industry lead sponsor. The 10 most frequent:
Bozyaka Training and Research Hospital is the lead sponsor of 51 studies on the registry; 5 are open to participants now.
Bozyaka Training and Research Hospital has 3 studies filed under Spondylitis, Ankylosing — fewer than ten, so there is no comparison to draw.
9 of the studies in Spondylitis, Ankylosing with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07627542Merve ŞahinAn Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals With Rheumatoid Arthritis and Ankylosing Spondylitis | 2026-11 |
| NCT07170384Sinem Kübra BekeMediterranean Diet and Disease Activity in Axial Spondyloarthritis Receiving Biologic Therapy | 2027-01-01 |
| NCT07633730Marmara UniversityEfficacy of the Erector Spinae Plane Block for Persistent Back Pain in Patients With Ankylosing Spondylitis | 2027-05-02 |
| NCT05096767Bozyaka Training and Research HospitalNeuropathic Spinal Pain Descriptors in Ankylosing Spondylitis | 2027-05-05 |
| NCT07776652Istanbul University - CerrahpasaPostural Biofeedback and Exercise in Axial Spondyloarthritis | 2027-05-30 |
Add all 9 to your calendar (.ics) → With an account.
Among the 84 studies in Spondylitis, Ankylosing with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The investigators have aimed to explore and interpret the neuropathic pain (NP) descriptors of spinal pain in patients with ankylosing spondylitis (AS). For this purpose they have attempted to initiate a prospective, cross-sectional study with AS patients.
NP descriptors have been investigated in several pain syndromes such as post-herpetic neuralgia, post-surgical nerve trauma, peripheral diabetic neuropathy and low back pain. But there is no study examining descriptors of inflammatory spinal pain with or without neuropathic characteristics seen in AS. To date, only one study reported distribution of sensory descriptors in neuropathic and non-neuropathic pain (nonNP) in AS patients, but in this paper the painful region was not specified and the results related to sensory descriptors were not discussed. Therefore, investigators have aimed to explore and interpret the sensory descriptors of inflammatory spinal pain in patients with AS. For this purpose investigators have attempted to initiate a study investigating whether sensory descriptors in neuropathic pain (NP) are differ from those seen in non-neuropathic pain (nonNP).
The aims of this study are;
AS patients suffering from spinal pain with severity of 3 or more on 10 cm VAS
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
questionnaires and inventories related to primary end secondary outcomes will be applied and physical examination will be performed
Neuropathic pain
It will be assessed using the painDETECT questionnaire. This questionnaire, contains nine questions all of which are selfreport. Seven items are rated on a six point Likert scale and thus are scored between 0-5. These seven questions query some sensations such as burning, tingling or prickling, allodynia, numbness etc. Apart from these seven items, one item assesses the radiation of pain and the other one item looks for the temporal characteristics of pain. A total score of 12 or less indicates neuropathic component is unlikely, 13-18 means possible neuropathic component and 19 or greater means a neuropathic component is likely. Beside these, there are three items in a separate section measuring severity of pain at the time of evaluation, on average and maximum over the past month. This section is not taken into account in scoring.
Time frame: Once, at baseline
Neuropathic pain descriptors
In the painDETECT questionnaire, seven items querying sensory abnormalities are scored between 0-5. Each of these abnormal sensations represent a pain descriptor. These descriptors are; burning, tingling, allodynia, pain attacks, thermal hyperalgesia, numbness and pressure hyperalgesia. A descriptor will accepted as positive if it is scored between 3 to 5
Time frame: Once, at baseline
Functional status
To measure functional status of patients, Bath Ankylosing Spondylitis Functional Index will be used. It is a 10 item questionnaire querying patients' ability in performing daily activities (such as dressing, bending forward, climbing stairs, reaching a shelf, etc.) on a line of 10 centimeters. The final score is the average of the items, between 0 (no limitation) to 10 (maximal limitation in function).
Time frame: Once, at baseline
Plan to share: No
Started Oct 2021 (actual). Primary completion is estimated for May 2027, 66 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bozyaka Training and Research Hospital